LUND, S.E., April 2, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces continued advancement in its sustainability journey, marked by a strengthened assessment from CDP, formerly the Carbon Disclosure Project.
LUND, S.E., March 25, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce that Miriam Martin, a long-standing member of the organization, has…
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce the appointment of Katarina Ageborg as Chairman of the Board and Markus Granlund as acting CEO, effective immediately.
TFS HealthScience proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This strategic shift underscores TFS’s commitment to advancing clinical research, improving patient outcomes, and fostering sustainable partnerships.
TFS HealthScience partners with RetinAI and MAXO to advance clinical studies in dry eye disease with AI-driven data management and innovative solutions.
TFS appoints Kris O’Brien as VP, Head of Oncology & Rare Diseases, enhancing leadership in clinical trials for complex therapies.
Leading CRO, TFS HealthScience appoints Victoria Hornagold as VP of Clinical Development Services, enhancing client delivery with a patient-centric focus.
TFS HealthScience achieves top 15% ranking with a Silver Rating from EcoVadis, underscoring our dedication to sustainability and responsible business practices.
TFS HealthScience announces the release of its Sustainability Report 2023, showcasing significant strides in environmental stewardship, social responsibility, and sustainable business practices.
TFS HealthScience, a leading global CRO, announces a noteworthy milestone in its commitment to environmental transparency and sustainability.
LUND, S.E., March 11, 2024 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an…
Aims to enhance global trial recruitment and operations, reach underrepresented populations, help lower costs and increase speed to commercialization. Will leverage real-world data and evidence (RWD/RWE) and artificial intelligence (AI)-enabled…
LUND, Sweden (Nov. 6, 2023) – TFS HealthScience, a global contract research organization (CRO), announces its strategic investment in Medidata Detect, a comprehensive data surveillance and risk monitoring solution that…
LUND, S.E., 28 Jun 2023 – TFS HealthScience, a premier global contract research organization, is proud to announce that for the fourth consecutive year, it has received a Silver Rating…
LUND, S.E., 27 Mar 2023 – Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand. TFS Portugal will increase…
